{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,22]],"date-time":"2026-01-22T23:30:08Z","timestamp":1769124608817,"version":"3.49.0"},"reference-count":6,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2020,5,1]],"date-time":"2020-05-01T00:00:00Z","timestamp":1588291200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,5,1]],"date-time":"2020-05-01T00:00:00Z","timestamp":1588291200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,2,7]],"date-time":"2020-02-07T00:00:00Z","timestamp":1581033600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100005247","name":"University of British Columbia","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100005247","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cjcopen.ca","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["CJC Open"],"published-print":{"date-parts":[[2020,5]]},"DOI":"10.1016\/j.cjco.2020.02.002","type":"journal-article","created":{"date-parts":[[2020,2,12]],"date-time":"2020-02-12T06:17:14Z","timestamp":1581488234000},"page":"176-178","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"title":["Severe Hypoglycemia in a Patient With Type 1 Diabetes Mellitus Recently Started on Sacubitril\/Valsartan: A Case Report"],"prefix":"10.1016","volume":"2","author":[{"given":"Arden R.","family":"Barry","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.cjco.2020.02.002_bib1","series-title":"Entresto (sacubitril\/valsartan film-coated tablets) [product monograph]","year":"2017"},{"key":"10.1016\/j.cjco.2020.02.002_bib2","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1038\/clpt.1981.154","article-title":"A\u00a0method for estimating the probability of adverse drug reactions","volume":"30","author":"Naranjo","year":"1981","journal-title":"Clin Pharmacol Ther"},{"key":"10.1016\/j.cjco.2020.02.002_bib3","doi-asserted-by":"crossref","first-page":"1254","DOI":"10.1177\/1932296818785644","article-title":"Reduction of insulin requirement after starting treatment with sacubitril\/valsartan in a patient with diabetes treated with continuous subcutaneous insulin infusion (CSII): a case report","volume":"12","author":"Gamarra","year":"2018","journal-title":"J\u00a0Diabetes Sci Technol"},{"key":"10.1016\/j.cjco.2020.02.002_bib5","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1056\/NEJMoa1409077","article-title":"Angiotensin-neprilysin inhibition versus enalapril in heart failure","volume":"371","author":"McMurray","year":"2014","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.cjco.2020.02.002_bib6","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/S2213-8587(17)30087-6","article-title":"Effect of sacubitril\/valsartan versus enalapril on glycaemic control in patients with heart failure and diabetes: a post-hoc analysis of the PARADIGM-HF trial","volume":"5","author":"Seferovic","year":"2017","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/j.cjco.2020.02.002_bib7","doi-asserted-by":"crossref","first-page":"1923","DOI":"10.1161\/01.CIR.0000062646.09566.CC","volume":"107","author":"Wang","year":"2003","journal-title":"Circulation"}],"container-title":["CJC Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2589790X20300135?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2589790X20300135?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,11]],"date-time":"2025-11-11T23:02:41Z","timestamp":1762902161000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2589790X20300135"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,5]]},"references-count":6,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2020,5]]}},"alternative-id":["S2589790X20300135"],"URL":"https:\/\/doi.org\/10.1016\/j.cjco.2020.02.002","relation":{},"ISSN":["2589-790X"],"issn-type":[{"value":"2589-790X","type":"print"}],"subject":[],"published":{"date-parts":[[2020,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Severe Hypoglycemia in a Patient With Type 1 Diabetes Mellitus Recently Started on Sacubitril\/Valsartan: A Case Report","name":"articletitle","label":"Article Title"},{"value":"CJC Open","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cjco.2020.02.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Canadian Cardiovascular Society. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}